Search results for "N-2"

showing 10 items of 1881 documents

CCDC 1029116: Experimental Crystal Structure Determination

2015

Related Article: Alexander N. Chernyshev, Maria V. Chernysheva, Pipsa Hirva, Vadim Yu. Kukushkin, Matti Haukka|2015|Dalton Trans.|44|14523|doi:10.1039/C4DT03167A

2-(pyrimidin-2-yl)pyrimidin-1-ium tetrachloro-gold(iii)Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1029122: Experimental Crystal Structure Determination

2015

Related Article: Alexander N. Chernyshev, Maria V. Chernysheva, Pipsa Hirva, Vadim Yu. Kukushkin, Matti Haukka|2015|Dalton Trans.|44|14523|doi:10.1039/C4DT03167A

2-(quinolin-2-yl)quinolinium tetrabromo-gold(iii)Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1549500: Experimental Crystal Structure Determination

2017

Related Article: Brian M. Barry, R. Graeme Soper, Juha Hurmalainen, Akseli Mansikkamäki, Katherine N. Robertson, William L. McClennan, Alex J. Veinot, Tracey L. Roemmele, Ulrike Werner-Zwanziger, René T. Boeré, Heikki M. Tuononen, Jason A. C. Clyburne, Jason D. Masuda|2018|Angew.Chem.,Int.Ed.|57|749|doi:10.1002/anie.201711031

2-{[4-(chloroethynyl)phenyl]ethynyl}-13-bis[26-bis(propan-2-yl)phenyl]-45-dihydro-1H-imidazol-3-ium 2-{[4-(bromoethynyl)phenyl]ethynyl}-13-bis[26-bis(propan-2-yl)phenyl]-45-dihydro-1H-imidazol-3-ium tetraphenylborate dichloromethane solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 871116: Experimental Crystal Structure Determination

2015

Related Article: Michael Mirion, Lars Andernach, Caroline Stobe, Joaquin Barjau, Dieter Schollmeyer, Till Opatz, Arne Lützen, Siegfried R. Waldvogel|2015|Eur.J.Org.Chem.|2015|4876|doi:10.1002/ejoc.201500600

21-ethyl-5710121618-hexamethyl-31423-trioxa-21-azahexacyclo[11.7.3.0113.0210.049.01520]tricosa-46811151719-heptaen-22-oneSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Nenukleozīdu HIV – 1 reversās transkriptāzes inhibitoru sintēze

2016

Nenukleozīdu HIV – 1 reversās transkriptāzes inhibitoru sintēze. Pustenko A., zinātniskie vadītāji Dr. chem. Žalubovskis R, Dr. chem. Igors Kļimenkovs. Maģistra darbs 71 lappuses, 58 attēli, 20 tabulas, 33 literatūras avoti. Latviešu valodā. Darbā tika sintezēti 3,4-dihidropirimidīn-2(1H)-oni un to mono- N-1 un N-1, N-3 bisatvasinājumi reakcijās ar virkni sulfonilhlorīdu un acilhlorīdu. Sintezēto savienojumu struktūra apstiprināta ar KMR spektriem, kā arī ar Rentgenstruktūranalīzi. Literatūras apskatā apkopota informācija par 3,4-dihidropirimidīn-2(1H)-onu sintēzes metodēm, to acilēšanu un sulfonilēšanu.

34-DIHIDROPIRIMIDĪN-2(1H)-ONISULFONILHLORĪDIACILĒŠANASULFONILĒŠANARENTGENSTRUKTŪRAĶīmija
researchProduct

CCDC 891057: Experimental Crystal Structure Determination

2012

Related Article: G.Bentabed-Ababsa, S.Hamza-Reguig, A.Derdour, L.R.Domingo, J.A.Saez, T.Roisnel, V.Dorcet, E.Nassar, F.Mongin|2012|Org.Biomol.Chem.|10|8434|doi:10.1039/c2ob26442k

35-Diphenylfuran-22(5H)-dicarbonitrileSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1862873: Experimental Crystal Structure Determination

2018

Related Article: A. Zagidullin, D. Islamov, E. Oshchepkova, P. Lonnecke, V. Miluykov|2018|Acta Crystallogr.,Sect.E:Cryst.Commun.|74|1336|doi:10.1107/S2056989018011775

3-(triphenylphosphoranylidene)-25-dihydrofuran-25-dione tetrahydrofuran solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Diastereoselective synthesis of 6-functionalized 4-aryl-1,3-oxazinan-2-ones and their application in the synthesis of 3-aryl-1,3-aminoalcohols and 6-…

2010

Abstract Halocyclocarbamation of benzyl N -(1-phenyl-3-butenyl)carbamates afforded 6-functionalized 4-aryl-1,3-oxazinan-2-ones with moderate to excellent diastereoselectivity depending on the N -substituent. Importantly, in contrast to reported cyclocarbamations of homoallylic carbamates, which are generally trans -diastereoselective, cyclization of N -unsubstituted Cbz-protected homoallylamines led to cis -1,3-oxazinan-2-ones, predominantly. The use of N -benzylated and in situ prepared N -silylated derivatives resulted however in trans -selectivity. Transition states are proposed to explain the stereochemical influence of the N -substituent on the cyclocarbamations. The functionalized 1,3…

3-AminoalcoholsStereochemistry3-ASYMMETRIC INDUCTION1SubstituentBiochemistrychemistry.chemical_compound4-dionesCHIRAL BUILDING-BLOCKDrug DiscoveryHEIMIA-SALICIFOLIAArylOrganic ChemistryCONCISE SYNTHESISHOMOALLYLIC AMINESTransition stateALPHA-AMINO-ACIDSChemistrySTEREOSELECTIVE-SYNTHESISCyclocarbamationSTREPTOMYCES-CLAVULIGERUSchemistryASYMMETRIC TOTAL-SYNTHESISINTRAMOLECULAR AMIDOALKYLATION3-Oxazinan-2-onesPiperidine-2
researchProduct

CCDC 1040500: Experimental Crystal Structure Determination

2015

Related Article: Zsolt Szakonyi, Árpád Csőr, Matti Haukka, Ferenc Fülöp|2015|Tetrahedron|71|4846|doi:10.1016/j.tet.2015.05.019

3-carboxy-77-dimethylbicyclo[4.1.0]heptan-2-aminium chlorideSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation.

2017

Abstract In this paper, we describe the preparation of polymeric nanoparticles (NPs) loaded with sorafenib for the treatment of hepatocellular carcinoma (HCC). A synthetic brush copolymer, named PHEA-BIB-ButMA (PBB), was synthesized by Atom Trasnfer Radical Polymerization (ATRP) starting from the α-poly( N -2-hydroxyethyl)- d , l -aspartamide (PHEA) and poly butyl methacrylate (ButMA). Empty and sorafenib loaded PBB NPs were, then, produced by using a dialysis method and showed spherical morphology, colloidal size, negative ζ potential and the ability to allow a sustained sorafenib release in physiological environment. Sorafenib loaded PBB NPs were tested in vitro on HCC cells in order to e…

3003MaleHepatocellular carcinomamedicine.medical_treatmentPharmaceutical Science02 engineering and technologyATRPPharmacology01 natural sciencesDrug Delivery SystemsCopolymerChemistryATRP; Hepatocellular carcinoma; Sorafenib; Tumor targeting; α-Poly(N-2-hydroxyethyl)-DL-aspartamide; 3003Liver NeoplasmsSorafenib021001 nanoscience & nanotechnologyDrug delivery0210 nano-technologymedicine.drugSorafenibNiacinamideCarcinoma HepatocellularCell SurvivalRadical polymerizationIntraperitoneal injectionL-aspartamideMice NudeAntineoplastic AgentsEnhanced permeability and retention effect010402 general chemistryPolymethacrylic AcidsIn vivoCell Line TumormedicineAnimalsHumansneoplasmsProtein Kinase InhibitorsPhenylurea Compoundstechnology industry and agriculturedigestive system diseasesIn vitro0104 chemical sciencesDrug LiberationTumor targetingDelayed-Action PreparationsBiophysicsα-Poly(N-2-hydroxyethyl)-DNanoparticlesα-Poly(N-2-hydroxyethyl)-DL-aspartamidePeptidesJournal of controlled release : official journal of the Controlled Release Society
researchProduct